Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 2.1B | 2.2B | 2.1B |
Cost of revenue | 1.7B | 1.7B | 1.7B | 1.6B |
Gross profit | 454.7M | 469.7M | 505.2M | 437.7M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 161.4M | 147M | 162M | 149.5M |
Other operating expenses | — | — | — | — |
Operating income | 293.3M | 322.7M | 343.2M | 288.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 12.9M | 11.7M | 9.7M | 10.4M |
Other income expense | -13M | -19.4M | -14.9M | -11.1M |
Pretax income | 267.4M | 291.6M | 318.6M | 266.7M |
Tax provision | 63.6M | 70.5M | 80.5M | 67.8M |
Net income | 203.8M | 221.1M | 238.1M | 198.9M |
Basic EPS | 2.3 | 2.5 | 2.7 | 2.2 |
Diluted EPS | 2.3 | 2.5 | 2.6 | 2.2 |
Basic average shares | 89.2M | 89.9M | 89.1M | 89.1M |
Diluted average shares | 89.6M | 89.9M | 89.5M | 89.5M |
EBITDA | 428.8M | 452.8M | 472.7M | 413.1M |
Net income from continuing op. | 203.8M | 221.1M | 238.1M | 199M |
Minority interests | — | — | — | — |
Preferred stock dividends | 1.4M | 1.5M | 1.7M | 1.4M |